Selecting optimum antihypertensive therapy: indications for choosing a calcium channel blocker

M B Murphy1

  • 1Committee on Clinical Pharmacology, University of Chicago, Illinois 60637.

Insights

Selecting the best antihypertensive medication involves considering patient demographics, lifestyle, and coexisting conditions. Optimal therapy ensures 24-hour blood pressure control, improving patient compliance and outcomes.

Area of Science:

  • Cardiovascular Medicine
  • Pharmacology
  • Internal Medicine

Background:

  • Individualized antihypertensive therapy requires careful consideration of numerous patient-specific factors.
  • Demographic characteristics, circadian blood pressure patterns, and coexisting conditions influence treatment response.
  • Potential drug interactions and patient lifestyle factors are critical in selecting appropriate antihypertensive agents.

Purpose of the Study:

  • To review the key factors influencing the selection of optimal antihypertensive agents for individual patients.
  • To highlight the importance of considering demographic, clinical, and lifestyle variables in hypertension management.
  • To emphasize the need for antihypertensive therapies that ensure 24-hour blood pressure control and promote patient compliance.

Main Methods:

  • Review of current literature and clinical guidelines on hypertension management.
  • Analysis of factors affecting antihypertensive drug efficacy and patient adherence.
  • Discussion of the role of different antihypertensive drug classes, including calcium channel blockers.

Main Results:

  • Patient age, gender, race, and circadian blood pressure patterns impact antihypertensive treatment outcomes.
  • Concomitant medical conditions and potential drug interactions necessitate thorough patient evaluation.
  • Lifestyle, economic status, and dosing frequency significantly influence the choice and effectiveness of antihypertensive medications.

Conclusions:

  • Optimal antihypertensive therapy is tailored to the individual patient, considering a wide range of factors.
  • Calcium channel blockers offer versatility across age groups and are beneficial for specific concurrent conditions.
  • Achieving 24-hour blood pressure control through appropriate agent selection is crucial for managing hypertension effectively and improving patient compliance.

Related Concept Videos

Antihypertensive Drugs: Action of Calcium Channel Blockers01:18

Antihypertensive Drugs: Action of Calcium Channel Blockers

Calcium ions are essential to contract smooth muscle cells in blood vessels. They enter these cells through voltage-dependent calcium channels, specifically L-type calcium channels in the cell membrane. These L-type calcium channels are integral to the excitation-contraction coupling process in smooth muscle. When a stimulus is received by smooth muscle cells, their membrane depolarizes. This alteration in membrane potential instigates the opening of L-type calcium channels. As a result,...
Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers01:22

Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers

Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers01:20

Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers

Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Antianginal Drugs: Calcium Channel Blockers and Ranolazine01:25

Antianginal Drugs: Calcium Channel Blockers and Ranolazine

Angina pectoris, a primary symptom of ischemic heart disease, requires careful pharmacological interventions. In this context, calcium channel blockers (CCBs) and ranolazine have emerged as crucial pharmacotherapeutic agents, providing deep insights into the complexities of angina management.
CCBs, a diverse class that includes dihydropyridines (nifedipine) and diphenylalkylamines (verapamil and diltiazem), exert their effect by blocking calcium channels in cardiac and smooth muscle cells. This...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers01:26

Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers

Receptor tyrosine kinase inhibitors (TKIs) and calcium channel blockers (CCBs) are two critical categories of drugs employed in the treatment of pulmonary artery hypertension (PAH). PAH is a disease that causes high blood pressure in the pulmonary arteries, resulting in chest pain, fatigue, and shortness of breath.
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Hypertension IV: Drug Therapy and Lifestyle Modifications01:28

Hypertension IV: Drug Therapy and Lifestyle Modifications

Multiple classes of antihypertensive medications are employed in treating hypertension. The most commonly recommended first-line treatments include:Thiazide Diuretics, such as chlorthalidone, increase sodium and water excretion from the body, reducing blood volume and blood pressure.Angiotensin-converting enzyme inhibitors, like lisinopril, block the conversion of angiotensin I to II, a potent vasoconstrictor lowering blood pressure.Angiotensin II Receptor Blockers (ARBs) prevent angiotensin II...